LMRI Lumexa Imaging Holdings, Inc.
Lumexa Imaging Holdings (LMRI) news
Lumexa Imaging Holdings, Inc. is a public biotech or pharmaceutical company listed on NASDAQ under the ticker LMRI, recorded under United States. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.
Latest Lumexa Imaging Holdings news
We have not published a story on Lumexa Imaging Holdings yet. When there is news, it will appear here.
Questions about Lumexa Imaging Holdings
What is the ticker symbol of Lumexa Imaging Holdings?
Lumexa Imaging Holdings, Inc. trades under the ticker LMRI on NASDAQ.
Where is Lumexa Imaging Holdings listed?
Lumexa Imaging Holdings, Inc. is listed on NASDAQ.
Which country or territory is Lumexa Imaging Holdings listed under?
Our directory records Lumexa Imaging Holdings, Inc. under United States.
Does aibio.space cover Lumexa Imaging Holdings?
aibio.space lists Lumexa Imaging Holdings, Inc. among 2,820 public biotech companies and publishes its news here as stories appear.
Investor discussion: Lumexa Imaging Holdings
Rules
- Securities violations are strictly forbidden. No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information.
- Say whether you hold the stock. Every post states long, short or no position.
- No paid or sponsored posts. Do not post for anyone who pays or rewards you.
- No buy or sell calls and no price targets.
- No accusations of crime or fraud against named people unless you link a court filing or a regulator's release that makes them.
- No personal details and no spam. No links at all for your first 7 days as a member.
Capital-markets timeline
- Legal
Disclosed a shareholder lawsuit, subpoena or other legal matter. SEC Form 10-Q. Source
Stock chart
Listing details
- Company
- Lumexa Imaging Holdings, Inc.
- Ticker
- LMRI
- Listing
- NASDAQ
- Country or territory
- United States
Who manages this page This page is managed by aibio.space. The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. How we work · Terms · Request a correction
aibio